2016 AIChE Annual Meeting

Session: Materials Science in Pharmaceutical Process Development II

Material science understanding is a key factor to consider in drug substance and drug product process development. The material properties for the API, excipients, and intermediates can influence the process and product performance. This session focuses on the application of material science to guide drug substance and drug product development. Of particular interest is work related to elucidate key material attributes impacting process and product performance as well as the application of the novel material property tool or data to gain further process understanding.

Chair

Shrikant Khot, The Dow Chemical Co.

Co-Chair

Bei Chen, AbbVie

Presentations

03:15 PM

Ping Gao, Maxx Capece, Raimundo Ho, David O'Brien, Ahmad Sheikh, John C. Strong, Divya Sunkara

03:35 PM

Jaime Curtis-Fisk, TRUE Rogers,, Karen Balwinski, Kathryn Hewlett, Robert Schmitt, Shrikant Khot

03:55 PM

04:15 PM

Eva Faulhammer, Sandra Stranzinger, Peter Loidolt, Vittorio Calzolari, Stefano Biserni, Amrit Paudel, Johannes G. Khinast, Stanko Srcic, Rok Dreu

04:35 PM

04:55 PM

Thomas Baxter, Roger Barnum, James K. Prescott, John Carson

05:15 PM

Jon Hilden, Mark Polizzi, Aaron Zettler